Prevalence of Posttranscatheter Aortic Valve Implantation Vascular Complications in Real Life. (12th October 2021)

• Record Type: Journal Article
• Authors: Matta, Anthony; Canitrot, Ronan; Nader, Vanessa; Bouisset, Frederic; Lhermusier, Thibault; Campelo-Parada, Francisco; Grunenwald, Etienne; Marcheix, Bertrand; Elbaz, Meyer; Carrie, Didier; Roncalli, Jerome
• Other Names: Rigattieri Stefano Academic Editor.
• Is Part Of: Journal of interventional cardiology. Volume 2021(2021)
• Publication Date: 2021-10-12
• Subjects: Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.1206
• DOI: 10.1155/2021/5563486
• Languages: English
• ISSNs: 0896-4327

Abstract

Abstract : Background . Vascular complications (VCs) are commonly observed after transfemoral transcatheter aortic valve implantation (TAVI) procedures. Closure devices for the access site were developed to reduce their incidence. We aim to evaluate the prevalence, predictors, and outcomes of the occurrence of post-TAVI VCs. Materials and Methods . A retrospective study was conducted on 1336 consecutive patients who underwent TAVI at the University Hospital of Toulouse, France, between January 2016 and March 2020. All included procedures were performed through the common femoral artery, and ProGlide ® was the used closure device. The studied population was divided into two groups depending on the occurrence of VCs defined according to Valve Academic Research Consortium-2 criteria. Results . The mean age of the studied population was 84.4 ± 6.9, and 48% were male. 90% of TAVI interventions were performed through the right femoral artery. The prevalence of VCs was 18.8%, and 3.7% were major. Prolonged procedure duration was an independent predictor of VCs. Using the right access site and smaller introducer size (14 Fr) were preventive factors. No significant difference in mortality rate was detected between the two groups. Conclusion . This study showed a low prevalence for post-TAVI VCs, especially for the major type. An increase in bleeding events and prolonged cardiac care unit stay were the common adverse outcomes.